Detalles de la búsqueda
1.
Real-world safety of nusinersen in Japan: results from an interim analysis of a post-marketing surveillance and safety database.
Int J Neurosci
; 133(8): 851-863, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34809526
2.
Safety and effectiveness of nusinersen, a treatment for spinal muscular atrophy, in 524 patients: results from an interim analysis of post-marketing surveillance in Japan.
Int J Neurosci
; : 1-13, 2023 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37649429
3.
Real-world safety and effectiveness of nusinersen, a treatment for spinal muscular atrophy, in 401 Japanese patients: results from an interim analysis of post-marketing surveillance.
Int J Neurosci
; : 1-10, 2022 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35787224
4.
Safety and effectiveness of interferon ß-1a intramuscular therapy: results of the postmarketing drug surveillance in Japan.
Rinsho Shinkeigaku
; 57(10): 553-561, 2017 10 27.
Artículo
en Japonés
| MEDLINE | ID: mdl-28966229
5.
Safety and Effectiveness of Natalizumab: First Report of Interim Results of Post-Marketing Surveillance in Japan.
Neurol Ther
; 6(2): 197-211, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29119538
Resultados
1 -
5
de 5
1
Próxima >
>>